Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
GMS Ophthalmology Cases|April 7, 2018
Central serous chorioretinopathy with angioid streaks: a rare combinationAmbreen Sarmad, Fadi Alfaqawi, Monali Chakrabarti, et al.
European Journal of Ophthalmology|November 8, 2017
Active iris vascular tufts bleeding successfully treated with argon laser photocoagulationAmbreen Sarmad, Fadi Alfaqawi, Monali Chakrabarti, et al.
Scientific Reports|November 3, 2021
Role of minimally invasive glaucoma surgery in the management of chronic open-angle glaucomaOjasvi Sharma, Didar Abdulla, Anthony King, et al.
ACS Chemical Neuroscience|September 16, 2022
Inhibition of Autotaxin Ameliorates LPA-Mediated Neuroinflammation and Alleviates Neurological Dysfunction in Acute Hepatic EncephalopathySubhasis Roy, Monali Chakrabarti, Hemantika Dasgupta, et al.
ACS Pharmacology & Translational Science|September 19, 2024
Effect of an Autotaxin Inhibitor, 2-(4-Chlorophenyl)-7-methyl-8-pentylimidazo[1,2-a] Pyrimidin-5(8H)-one (CBT-295), on Bile Duct Ligation-Induced Chronic Liver Disease and Associated Hepatic Encephalopathy in RatsSubhasis Roy, Monali Chakrabarti, Trisha Mondal, et al.
Chemical Biology & Drug Design|December 24, 2021
Structure-based discovery of (S)-2-amino-6-(4-fluorobenzyl)-5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione as low nanomolar, orally bioavailable autotaxin inhibitorAshis Roy, Tonmoy Sarkar, Sebak Datta, et al.
Chemical Biology & Drug Design|November 2, 2022
Identification of 5-(3-(methylsulfonyl)phenyl)-3-(4-(methylsulfonyl)phenyl)-3H-imidazo[4,5-b]pyridine as novel orally bioavailable and metabolically stable antimalarial compound for further explorationMrinalkanti Kundu, Aditi Dutta, Kuldeep K Roy, et al.
Pageof 1